Versigent Limited (VGNT)

We still think the shares of Versigent (VGNT; $39.00; O/P) look undervalued, after it reported Q1 results, its first as a public company since being spun out from Aptiv (APTV; $57.11; O/P), which included a…

We initiate coverage of the shares of Versigent (VGNT; $28.34) with an Outperform and $35 target given our belief that the stock looks like a mispriced asset after being spun out by Aptiv (APTV; $60.63;…